Simulated concentration–time profiles across various covariate subgroups revealed a dominant effect of ADA on CLL, particularly for the models developed by Hanzel et al. [14] and Okamoto et al. [3] (Figures S1 and S2). This evidence concerns the gene ADA and B-cell chronic lymphocytic leukemia.